Valuation: DexCom, Inc.

Market Cap 31.07B 175B 28.16B 26.05B 23.5B 44.29B 2,930B 45.85B 313B 124B 1,565B 117B 114B 4,968B P/E 2026 *
32.7x
P/E 2027 * 27.6x
Enterprise Value 30.73B 173B 27.85B 25.76B 23.24B 43.8B 2,898B 45.34B 309B 123B 1,548B 115B 113B 4,913B EV / Sales 2026 *
5.88x
EV / Sales 2027 * 5.23x
Free-Float
90.14%
Yield 2026 *
-
Yield 2027 * -
1 day+1.40%
1 week+1.94%
Current month+8.38%
1 month+11.32%
3 months+1.72%
6 months+64.17%
Current year+26.03%
1 week 8.46
Extreme 8.46
9.44
1 month 7.79
Extreme 7.79
9.77
Current year 5.75
Extreme 5.75
9.77
1 year 5.75
Extreme 5.75
9.77
3 years 5.75
Extreme 5.75
14.45
5 years 5.75
Extreme 5.75
18.3
10 years 5.75
Extreme 5.75
18.3
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.40%+1.94% - - 30.35B
+1.18%-1.28%-16.05%+13.29% 186B
+1.85%+1.04%+6.99%+42.70% 124B
-0.88%-4.98%-17.08%+9.86% 119B
+1.36%-5.00%-43.14%+4.26% 91.43B
+2.96%+7.64%-1.76%+80.54% 66.67B
+1.08%+2.90%+12.95%-7.56% 58.76B
+0.89%+4.17%+0.39%+62.87% 54.99B
-0.68%-0.62%-2.41%+56.27% 49.93B
-1.28%-0.43% - - 35.13B
Average +0.51%-1.93%-7.51%+32.78% 87B
Weighted average by Cap. +0.49%-3.32%-10.06%+27.33%

Financials

2026 *2027 *
Net sales 5.23B 29.48B 4.74B 4.38B 3.95B 7.45B 493B 7.71B 52.64B 20.87B 263B 19.62B 19.2B 836B 5.77B 32.56B 5.23B 4.84B 4.37B 8.23B 544B 8.52B 58.15B 23.06B 291B 21.67B 21.21B 923B
Net income 980M 5.52B 888M 821M 741M 1.4B 92.39B 1.45B 9.87B 3.91B 49.35B 3.68B 3.6B 157B 1.14B 6.44B 1.04B 958M 864M 1.63B 108B 1.69B 11.51B 4.56B 57.57B 4.29B 4.2B 183B
Net Debt -343M -1.94B -311M -288M -260M -490M -32.39B -507M -3.46B -1.37B -17.3B -1.29B -1.26B -54.92B -888M -5B -804M -744M -671M -1.26B -83.69B -1.31B -8.94B -3.54B -44.7B -3.33B -3.26B -142B
Projected Income Statement - Annual - DexCom, Inc.
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-11-13 R$9.440 +3.28% 13
26-11-12 R$9.140 +2.47% 648
26-11-11 R$8.920 +0.11% 261
26-11-10 R$8.910 +0.91% 111
26-11-09 R$8.830 +0.80% 259
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - DexCom, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
83.32USD
Average target price
98.58USD
Spread / Average Target
+18.31%